Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Pediatric Neoplasm: early-phase trial registry

1 of 2 indexed Pediatric Neoplasm trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Pediatric Neoplasm: 2 US clinical trials tracked, 1 recruiting.

Pediatric Neoplasm is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Sabine Mueller, MD, PhD, running 1 of these trials.

Enrollment posture brief

Registry condition pediatric-neoplasm

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Pediatric Neoplasm (this)50%
Open-enrollment share among volume-matched conditions near Pediatric Neoplasm

Pediatric Neoplasm lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pediatric Neoplasm on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pediatric Neoplasm is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Pediatric Neoplasm records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Feedback of patient-reported outcomes Other
1 trials
Routine Data collection Other
1 trials
Implantation Procedure
1 trials
Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells Biological
1 trials
Magnetic Resonance Imaging (MRI) Procedure
1 trials
Quality-of-Life Assessment Other
1 trials

US sites by state

Facility locations filed on Pediatric Neoplasm trials. A trial with sites in several states counts in each.

Washington 2 trials
Pennsylvania 1 trials
Ohio 1 trials
New Jersey 1 trials
Missouri 1 trials
Maryland 1 trials
Massachusetts 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pediatric Neoplasm page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pediatric Neoplasm condition card totals 2 registered trials; most-linked intervention Feedback of patient-reported outcomes; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.